BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8679464)

  • 1. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections.
    Pfeiffer P; Clausen PP; Andersen K; Rose C
    Br J Cancer; 1996 Jul; 74(1):86-91. PubMed ID: 8679464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
    Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
    Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis.
    Pfeiffer P; Nexø E; Bentzen SM; Clausen PP; Andersen K; Rose C
    Br J Cancer; 1998 Jul; 78(1):96-9. PubMed ID: 9662257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.
    Onn A; Choe DH; Herbst RS; Correa AM; Munden RF; Truong MT; Vaporciyan AA; Isobe T; Gilcrease MZ; Marom EM
    Radiology; 2005 Oct; 237(1):342-7. PubMed ID: 16183941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.
    Giatromanolaki A; Gorgoulis V; Chetty R; Koukourakis MI; Whitehouse R; Kittas C; Veslemes M; Gatter KC; Iordanoglou I
    Anticancer Res; 1996; 16(2):987-93. PubMed ID: 8687165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
    J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor.
    Koo JS; Kim SH
    Neoplasma; 2011; 58(1):27-34. PubMed ID: 21067263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
    Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
    J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptors in non-small cell lung cancer.
    Veale D; Ashcroft T; Marsh C; Gibson GJ; Harris AL
    Br J Cancer; 1987 May; 55(5):513-6. PubMed ID: 3038157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of overexpressed matrix metalloproteinase-2, mouse-double minute: 2 homolog and epidermal growth factor receptor in non-small cell lung cancer.
    Jiang LY; Bi R; Ding FB; Wang MS; Mei J; He Y
    J BUON; 2016; 21(2):341-8. PubMed ID: 27273943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.
    Tran TA; Kallakury BV; Ambros RA; Ross JS
    Cancer; 1998 Jul; 83(2):276-82. PubMed ID: 9669810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
    Rachwal WJ; Bongiorno PF; Orringer MB; Whyte RI; Ethier SP; Beer DG
    Br J Cancer; 1995 Jul; 72(1):56-64. PubMed ID: 7599067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidermal growth factor receptor in non-small cell cancer of the lung].
    Díez M; Maestro ML; Torres A; Hernando F; Ortega MD; García-Asenjo JA; Picardo A; Mugüerza JM; Sánchez-Pernaute A; Balibrea JL
    Arch Bronconeumol; 1994; 30(6):282-6. PubMed ID: 8087386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival.
    Veale D; Kerr N; Gibson GJ; Kelly PJ; Harris AL
    Br J Cancer; 1993 Jul; 68(1):162-5. PubMed ID: 8391303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B.
    Wakata K; Tsuchiya T; Tomoshige K; Takagi K; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Whitsett JA; Maeda Y; Nagayasu T
    BMJ Open; 2015 Jul; 5(7):e008366. PubMed ID: 26224019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer.
    Okita R; Maeda A; Shimizu K; Nojima Y; Saisho S; Nakata M
    Cancer Immunol Immunother; 2017 Jul; 66(7):865-876. PubMed ID: 28341875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
    Dittadi R; Gion M; Pagan V; Brazzale A; Del Maschio O; Bargossi A; Busetto A; Bruscagnin G
    Br J Cancer; 1991 Oct; 64(4):741-4. PubMed ID: 1654986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
    Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
    Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
    Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco AR; Gullick W; Angeletti CA; Bevilacqua G; Ciardiello F
    Clin Cancer Res; 1998 Jan; 4(1):241-9. PubMed ID: 9516978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells.
    Tsai CM; Chang KT; Li L; Perng RP; Yang LY
    Jpn J Cancer Res; 2000 Feb; 91(2):213-22. PubMed ID: 10761709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.